TGF‐β converts NK cells into intermediate type 1 innate lymphoid cells (ILC‐1) in vitro and in vivo, suggesting TGFβ‐mediated NK plasticity and tumor escape by innate immunity [150, 151]. This evidence concerns the gene TGFB1 and neoplasm.